R/R HR-MDS

Clinical trials for R/R HR-MDS explained in plain language.

Never miss a new study

Get alerted when new R/R HR-MDS trials appear

Sign up with your email to follow new studies for R/R HR-MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New antibody GEN3018 enters first human trials for relapsed leukemia and MDS

Disease control Recruiting now

This early-stage trial tests a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS) has returned or stopped responding to treatment. The main goal is to check safety and find the right dose for future studies.…

Matched conditions: R/R HR-MDS

Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

Last updated May 20, 2026 11:54 UTC

R/R HR-MDS

Get alerted when new R/R HR-MDS trials appear

New antibody GEN3018 enters first human trials for relapsed leukemia and MDS